The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Nuvo Pharmaceuticals Inc unchanged

Nuvo Pharmaceuticals Inc closed unchanged Tuesday sitting at $0.00. This security is unchanged over the last five days and the last 52 weeks. This security has performed in-line with the S&P TSX during the last year.

Key company metrics

  • Trailing P/E--
  • P/E 1 year forward7.27×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS--
 Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue6688
Total other revenue--------
Total revenue6688
Gross profit3355
Total cost of revenue3333
Total operating expense4465
Selling / general / administrative1122
Research & development1000
Depreciation / amortization0000
Interest expense (income), net operating--00--
Unusual expense (income)--------
Other operating expenses, total--------
Operating income2122
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets000--
Other--------
Income before tax2122
Income after tax2122
Income tax, total0000
Net income212-1
Total adjustments to net income--------
Net income before extra. items2122
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2122
Inc. avail. to common incl. extra. items212-1
Diluted net income212-1
Dilution adjustment--00--
Diluted weighted average shares12121211
Diluted EPS excluding extraordinary itemsvalue per share0.150.100.210.17
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.150.100.210.17